Decrease in functional activity of G-proteins hormone-sensitive adenylate cyclase signaling system, during experimental type II diabetes mellitus

Bulletin of Experimental Biology and Medicine

Volumn 142, Issue 6, 2006, Pages 685-689

  Shpakov, A O ^a   Kuznetsova, L A ^a   Plesneva, S A ^a   Bondareva, V M ^b   Gur'yanov, I A ^b   Vlasov, G P ^b   Pertseva, M N ^b  

^a SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

^b INSTITUTE OF MACROMOLECULAR COMPOUNDS   (Russian Federation)

Author keywords

Adenylate cyclase; Diabetes; G protein; Myocardium; Relaxin

Indexed keywords

ADENYLATE CYCLASE; BROMOCRIPTINE; FORSKOLIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; RELAXIN; SOMATOSTATIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; ENZYME ACTIVITY; EXPERIMENTAL DIABETES MELLITUS; HEART MUSCLE; HORMONE ACTION; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; RAT; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

ADENYLATE CYCLASE; ANIMALS; BROMOCRIPTINE; CARDIOTONIC AGENTS; CORPUS STRIATUM; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FORSKOLIN; GTP-BINDING PROTEINS; HORMONE ANTAGONISTS; HORMONES; ISOPROTERENOL; MYOCARDIUM; PEPTIDES; RATS; RATS, WISTAR; RELAXIN; SEROTONIN; SEROTONIN AGENTS; SIGNAL TRANSDUCTION; SOMATOSTATIN;

RATTUS;

EID: 34147115813     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-006-0451-2     Document Type: Article

References (12)

1. A. O. Shpakov, I. A. Gur'yanov, L. A. Kuznetsova, et al., Biol. Membrany, 21, 441-450 (2004).
2. A. O. Shpakov, L. A. Kuznetsova, S. A. Plesneva, et al., Tsitologiya, 47, 540-548 (2005).
3. A. O. Shpakov, L. A. Kuznetsova, S. A. Plesneva, and M. N. Pertseva, Byull. Eksp. Biol. Med., 140, No. 9, 286-290 (2005).
4. A. O. Shpakov, M. N. Pertseva, I. A. Gur'yanov, and G. P. Vlasov, Biol. Membrany, 22, 435-442 (2005).
5. U. D. Dincer, K. R. Bidasee, S. Guner, et al., Diabetes, 50, 455-461 (2001).
6. S. Gando, Y. Hattori, Y. Akaishi, et al., J. Pharmacol. Exp. Therapeutics, 282, 475-484 (1997). 475-484 (1997).
7. S. J. Hemmings and D. Spafford, Int. J. Biochem. Cell Biol., 32, 905-919 (2000).
8. L. Kuznetsova, S. Plesneva, A. Shpakov, and M. Pertseva, Ann. NY Acad. Sci., 1041, 446-448 (2005).
9. C. Livingstone, A. R. McLellan, M. McGregor et al., Biochem. Biophys. Acta, 1096, 127-133 (1991).
10. T. M. Palmer, P. V. Taberner, and M. D. Houslay, Cell. Signall., 4, 365-377 (1992).
11. S. A. Plesneva, A. O. Shpakov, L. A. Kuznetsova, and M. N. Pertseva, Biochem. Pharmacol., 61, 1277-1291 (2001).
12. A. O. Shpakov, V. I. Korol'kov, S. A. Plesneva, et al., Neurosci. Behav. Physiol., 35, 177-186 (2005).